News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Changchun Technology Industries Pays $5 Million For Mucosis Stake


1/20/2014 5:31:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

January 17, 2014 -- Changchun High & New Technology Industries (Group) paid $4.8 million for a 25% interest in Dutch biopharma Mucosis BV. Mucosis is a clinical-stage biotech developing vaccines that can be administered needle-free via the nose or mouth through the mucosal membranes. Changchun is involved in a diverse range of industries, including real estate. Its life science products include generic drugs and biologics as well as TCM preparations. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES